In May 2020 the 2019 Annual Report showed that trade and other payables (liabilities) were $200m bigger than trade and other receivables (assets) - meaning, they are owed more than they owe. And the trade receivables moved less than 7% from 2018, not nearly enough for it to be sufficient to pad out the free cash flows. That is, free cash flow if you took out all trade payables/receivables would still be around $600m. I simply don't buy it.
Meanwhile, market is saying the same: CCL has broken up 2.5% today, and is now above the (softish) resistance around $9.30, and probably is heading towards the next level of around $9.90.
DYOR.
CCL Price at posting:
$9.48 Sentiment: Buy Disclosure: Held
